PCIM&H Initiates Five-Day Training Programme to Enhance ASU&H Drug Regulation and Quality Standards
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy inaugurated a five-day Capacity Building Training Programme for professionals involved in regulatory, academic, quality control, and manufacturing functions related to Ayurveda, Siddha, Unani, and Homoeopathy medicines. The programme, scheduled from November 24 to November 28, 2025, aims to strengthen the expertise of drug regulators, enforcement officials, quality control staff, technical specialists, government analysts, researchers, and scientists working in ASU&H drug development and quality assurance.
Dr. Preetha Kizhakkutil, Advisor (Homoeopathy), Ministry of Ayush, attended the inaugural session as the Chief Guest. She acknowledged the Commission’s contribution to establishing quality standards for ASU&H drugs, noting its use of advanced instruments and modern analytical methods.
Prof. (Dr.) Kashinath Samagandi, Director, Morarji Desai National Institute of Yoga and Naturopathy, Ministry of Ayush, spoke about the growing worldwide acceptance of the pharmacopoeias and formularies developed by PCIM&H. He stated that the rising global interest in ASU&H systems highlights India’s position in the field of traditional medicine.
Dr. Raman Mohan Singh, Director, PCIM&H, welcomed the attendees and shared insights into the Commission’s mandate, ongoing activities, and its work in developing standards and overseeing quality control for Indian systems of medicine. The event also featured Dr. N. Murugesan, Former Director of the Central Drug Testing Laboratory in Chennai, as the Special Guest.
Training Schedule and Technical Sessions
During the five-day programme, participants will engage in expert lectures, exposure visits, and practical sessions covering a wide array of topics. These include NABL Accreditation and Quality Management Systems, Good Manufacturing Practices, and various evaluation methods such as pharmacognostic, physico-chemical, phytochemical, microbiological, and pharmacological assessment of ASU&H drugs. Sessions will also address standardization and quality control of herbal drugs, regulatory and pharmacopoeial frameworks, and shelf-life studies.
The training further incorporates hands-on activities in PCIM&H laboratories and field visits to ASU&H drug manufacturing facilities. These include Dr. Willmar Schwabe India Pvt. Ltd. in Noida and Hamdard Laboratories India in Ghaziabad, providing participants with exposure to current technologies and industry practices.
National Participation
A total of 35 participants from various regions of the country are taking part in the programme. Attendees include State Drug Controllers, Drug Inspectors, Professors, Faculty Members, Research Officers, Ayush-accredited Drug Testing Laboratories, and representatives from National Institutes and Research Centres. Institutions represented include the National Institute of Siddha in Chennai, the National Institute of Ayurveda in Jaipur, the Siddha Central Research Institute in Chennai, the National Research Institute of Unani Medicine for Skin Disorders in Hyderabad, the Dr. D.P. Rastogi Central Research Institute for Homoeopathy in Noida, and the Regional Research Institute of Unani Medicine in Srinagar, along with several Ayush colleges and hospitals from Uttar Pradesh, Telangana, Assam, and Kanpur.
This Capacity Building Training Programme by PCIM&H reflects an effort to reinforce the regulatory framework for ASU&H drugs in India. By providing professionals with improved knowledge and practical exposure, the initiative contributes to maintaining quality standards and supporting the development of traditional medicine systems at the international level.